Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001351898 | SCV001546403 | uncertain significance | not provided | 2020-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 1059 of the RBP3 protein (p.Val1059Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with retinitis pigmentosa (PMID: 19074801). ClinVar contains an entry for this variant (Variation ID: 208324). This variant is not present in population databases (ExAC no frequency). |
Clin |
RCV000206919 | SCV000244076 | uncertain significance | Retinitis pigmentosa 66 | 2013-06-27 | no assertion criteria provided | literature only |